Hemodialysis patients who skipped the influenza vaccine were significantly more likely to be hospitalized than those who were vaccinated, suggests a three-year study of more than 150,000 kidney dialysis patients being presented today in Chicago at 2016 Kidney Week, the annual meeting of the American Society of Nephrology (ASN). The study is one of 66 abstracts authored by Fresenius Medical Care researchers, clinicians, and caregivers to be presented at the meeting and published in the Abstract Supplement of Journal of the American Society of Nephrology (JASN). This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161118005580/en/
FMCNA Chief Medical Officer and Executive VP, Dr. Frank Maddux, receives his annual flu shot from Clinic Manager, Margot Nelson, RN. (Credit: Fresenius Medical Care North America)The study tracked kidney failure patients who were vaccinated against the flu, including at U.S. Fresenius Kidney Care dialysis centers where they received their hemodialysis therapy. The percentage of Fresenius Kidney Care patients who opted for yearly vaccination against the flu increased from 60 percent the first year of the study to 80 percent the third year. Fresenius Medical Care North America is the premier health care company focused on providing the highest quality care to people with renal and other chronic conditions. "While almost everyone should be vaccinated against influenza, people with kidney failure who are on dialysis are at high risk for complications if they get sick, which is why it is vital they get the flu vaccine every year," said Nien Chen Li, MPH, MS, MA, lead author of the study and biostatistician for Fresenius Medical Care. "We're gratified to see that our patients are increasingly choosing to be vaccinated."